Construction of preoperative liver function assessment system for patients with hepatocellular carcinoma complicated with clinically significant portal hypertension

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Observational

Source

ChiCTR

Registry ID

ChiCTR2000036054

Enrollment

Unknown

Registered

2020-08-21

Start date

2021-01-01

Completion date

Unknown

Last updated

2020-08-31

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hepatocellular carcinoma with portal hypertension

Interventions

Gold Standard:Clinical outcome

Index test:preoperative&#32

liver&#32

function&#32

assessment&#32

system

Eligibility

Sex/Gender

All

Age

18 Years to 75 Years

Inclusion criteria

Inclusion criteria: (1) Aged 18 to 75 years; (2) Conform to CSPH and meet the surgical indication; (3) BCLC stage A; (4) Child-Pugh liver function Class A; (5) Informed consent from the patient.

Exclusion criteria

Exclusion criteria: (1) Presence of portal vein thrombosis, portal vein tumor thrombus, or previous portal vein embolisation; (2) Emergency hepatectomy and ruptured hepatocellular carcinoma; (3) Combined operation for extrahepatic disease; (4) Cardiopulmonary function is abnormal and cannot tolerate opera-tion, an ASA operative risk>=3; (5) With history of anti-cancer therapy.

Design outcomes

Primary

Measure	Time frame
SEN, SPE, ACC, AUC of ROC;	—

Contacts

Public ContactQu Shu-Ping

Shanghai Oriental Hepatobiliary Surgery Hospital

shupingqu33@sina.com+86 13916270526

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026